dc.contributor.author |
Mohammed, Osman Ali |
|
dc.contributor.author |
Ibrahim, Bakhit Yousif |
|
dc.contributor.author |
Ihsan, Mohammed Osman |
|
dc.contributor.author |
Elfatih, Mohammed Abdallah |
|
dc.contributor.author |
Abdelwahab, Abdien Saeed |
|
dc.date.accessioned |
2019-07-10T08:58:36Z |
|
dc.date.available |
2019-07-10T08:58:36Z |
|
dc.date.issued |
2019-06 |
|
dc.identifier.issn |
2349-0063 |
|
dc.identifier.uri |
http://hdl.handle.net/123456789/684 |
|
dc.description |
Breast cancer is the most frequently diagnosed and the leading cause of cancer death in women globally. Over the past few decades its incidence has increased but a fall in mortality has been observed due to improvement in survival which is associated with earlier disease detection. This is a prospective cross-sectional descriptive study based on laboratory data of (136) patients with breast cancer carried out from (2012-2017) in Nuclear Medicine and Cancer Research centre - Shendi University and Nuclear Medicine and Cancer Research Centre - Aljazeera University. The investigations were performed on venous blood sample drawn in EDTA container for complete blood count by using auto haematology analyzer (Mindray BC-3000 plus). Regarding anemia among breast cancer, 61/136 (44.9 %) were anemic, while 75/136 (55.1 %) were non anemic. There is high frequency of cancer related anaemia in breast cancer (44.9 %). |
en_US |
dc.description.abstract |
Breast cancer is the most frequently diagnosed and the leading cause of cancer death in women globally. Over the past few decades its incidence has increased but a fall in mortality has been observed due to improvement in survival which is associated with earlier disease detection. This is a prospective cross-sectional descriptive study based on laboratory data of (136) patients with breast cancer carried out from (2012-2017) in Nuclear Medicine and Cancer Research centre - Shendi University and Nuclear Medicine and Cancer Research Centre - Aljazeera University. The investigations were performed on venous blood sample drawn in EDTA container for complete blood count by using auto haematology analyzer (Mindray BC-3000 plus). Regarding anemia among breast cancer, 61/136 (44.9 %) were anemic, while 75/136 (55.1 %) were non anemic. There is high frequency of cancer related anaemia in breast cancer (44.9 %). |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
World Journal of Biology and Medical Sciences |
en_US |
dc.relation.ispartofseries |
Volume 6,;Issue-2, 17-22, April - June, 2019 |
|
dc.subject |
Breast cancer |
en_US |
dc.subject |
Sudan |
en_US |
dc.subject |
Anaemia |
en_US |
dc.subject |
cancer |
en_US |
dc.subject |
Breast |
en_US |
dc.title |
Breast Cancer Related Anaemias |
en_US |
dc.type |
Article |
en_US |